Stefan gave an oral presentation at the European Commission Joint Research Center at Ispra, Italy, October 2015
Why the quality of quality metrics counts in healthcare: an illustration from breast cancer surgery. Cano SJ, Pendrill LR. Putting Science into Standards: Evidence-based quality assurance – an example of breast cancer. European Commission Joint Research Centre, Ispra, Italy (October 2015)
Patrick and Stefan are co-authors of a publication on COAs
Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force. Walton MK, Powers JH 3rd, Hobart J, Patrick D, Marquis P, Vamvakas S, Isaac M, Molsen E, Cano S, Burke LB. Value Health. 2015 Sep;18(6):741-
The Making of Measurement, CRASSH University of Cambridge, UK , July 23-24, 2015
Stefan gave a talk on: “Social Measurement: Three Problems, Five Challenges, One Solution”.
ISPOR 20th Annual International Meeting, Philadelphia, May 16-20, 2015
Patrick spoke at ISPOR in a session about emerging good pratices in COAs.
CLINICAL OUTCOME ASSESSMENTS (COAS): A CONCEPTUAL FOUNDATION AND DEVELOPING AND EVALUATING CLINICIAN-REPORTED OUTCOME (CLINRO) INSTRUMENTS TO ASSESS TREATMENT BENEFIT: EMERGING GOOD PRACTICES
John H. Powers, MD, FACP, FIDSA, Associate Clinical Professor of Medicine, George Washington University School of Medicine, Washington, DC, USA
- Laurie B. Burke, RPh, MPH, Founder, Lora Group, LLC, Royal Oak, MD, USA and Former Director, Study Endpoints and Labeling Development, ONDIO, CDER, U.S. Food & Drug Administration, Silver Spring, MD, USA
- Donald Patrick, PhD, MSPH, Professor, Department of Health Services & Director, Seattle Quality of Life Group & Biobehavioral Cancer Training Program, University of Washington, Seattle, WA, USA
- Stefan Cano, PhD, CPsychol, AFBPsS, Co-Founder and Chief Science Officer, Modus Outcomes LLC, Stotfold, UK
- Patrick Marquis, MD, MBA, CEO, Modus Outcomes LLC, Newton, MA, USA
There is an urgent need for a standardized conceptual foundation for clinical outcome assessments (COAs) – ClinRO, ObsRO, PRO, or PerfO measures. The differences in each type of instrument dictate different approaches for development and evaluation. The Task Force undertook guidelines for ClinRO instruments. Task Force members will open discussion by defining what should be considered a ClinRO measure and providing a framework to describe these types of measures. They will present US (FDA) and European Medicines Agency (EMA) regulatory perspectives as well as their final recommendations on evaluation of ClinRO instruments for use to document treatment benefit. Identification of the treatment benefit and endpoint based on a ClinRO score, the concept of interest that is measured and context of use, evaluation of the instrument’s measurement properties will be included. Guidelines for interpretation and implementation in clinical trials conclude the discussion. The findings of these two Task Force reports will be very beneficial to those involved in evaluating treatment benefit using any type of COA. Presented by the ISPOR Clinical Outcomes Assessment – Emerging Good Practices Task Force
Poster Presented at ISPOR 20th Annual International Meeting, Philadelphia, USA
Cano, Cleanthous, Marquis, Hobart, Naoshy, Mikol. Measuring Upper Limb Function In Multiple Sclerosis: Enhancing The Abilhand’s Performance
IOMC :International Outcome Measurement Conference, Chicago, April 21-22, 2015:
Stefan gave two presentations:
– “Individual vs Group Level Measurement: Implications for Health Care Outcomes Economics”.
Symposium 1 – Plenary Session, Tuesday April 21, 8.15 am – 9.45 am
– with Thomas Salzberger: “Investigating a Lack of Discrimination between Two Adjacent Response Categories in the Rasch Model for Ordered Categories in Health Measurement”
Paper Session 9A, Wednesday April 22, 1.30 pm – 3.00 pm
Stefan also moderated Paper Session 4A on Tuesday April 21, 1.30 pm to 3.30 pm.
Two new publications IN FULL for Stefan:
FACE-Q Scales for Health-Related Quality of Life, Early Life Impact and Satisfaction with Outcomes and Decision to Have Treatment: Development and Validation. Klassen AF, Cano SJ, Schwitzer J, Scott A, Pusic AL. Plast Reconstr Surg. 2015 135(2):375-86.
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial. Prins MH, Bamber L, Cano SJ, Wang MY, Erkens P, Bauersachs R, Lensing AW. Thromb Res. 2015 Feb;135(2):281-8.
PROS: Patient -Reported Outcomes in Surgery Conference, Washington, DC, January 29-30, 2015
Stefan presented at the PROS conference last week: “New Psychometric Methods: Implications for Surgery”.
Stefan keeps on publishing and e-publishing!!:
Published in full, in 2015:
Using Classical Test Theory, Item Response Theory, and Rasch Measurement Theory to Evaluate Patient-Reported Outcome (PRO) Measures: A Comparison of Worked Examples. Value in Health. Petrillo J, Cano SJ, McLeod L, Coon C. Value Health. 2015 Jan;18(1):25-34.
Lending a hand: Can DASH items help ABILHAND improve manual ability measurement in multiple sclerosis? Barrett L, Cano SJ, Zajicek JP, Hobart JC. Mult Scler. 2015 Jan 12. [Epub ahead of print]
Copyright © 2018 Modus Outcomes®, All Rights Reserved